ZAI LAB LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.77 USD | +0.44% |
|
+2.32% | -24.00% |
| Aug. 07 | Sector Update: Health Care Stocks Lean Higher Pre-Bell Wednesday | MT |
| Aug. 07 | Transcript : Zai Lab Limited, Q2 2024 Earnings Call, Aug 07, 2024 |
Chart calendar Zai Lab Limited
1d8dba085ce6f.zKkVYpbB2sHqTtuNwWOfF-cMNbKbNJTH4WDZV3xh_j0.ju0gBuf0qfPfG4m08jvWdbJKY8r9VsDxlSWfHxEI01edkScP3rOVuZMh4w~b65328052196a656ea05c830c65a98ce
Upcoming events on Zai Lab Limited
Past events on Zai Lab Limited
| 2024-09-13 | European Society for Medical Oncology Meeting - Presentation No. 1008P |
| 2024-08-07 08:00 am | Q2 2024 Earnings Call |
| 2024-08-06 04:05 pm | Q2 2024 Earnings Release |
| 2024-06-18 08:00 am | Annual General Meeting |
| 2024-06-12 01:20 pm | Goldman Sachs Global Healthcare Conference |
| 2024-06-05 03:30 pm | Jefferies Global Healthcare Conference |
| 2024-05-22 10:00 pm | J.P. Morgan Global China Summit |
| 2024-05-09 08:00 am | Q1 2024 Earnings Call |
| 2024-05-08 04:05 pm | Q1 2024 Earnings Release |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Progress 2, CT155 / 6 |
| 2024-04-08 04:30 pm | American Association for Cancer Research Meeting - Progress 2, CT162 / 13 |
| 2024-03-22 07:00 am | European Lung Cancer Congress |
| 2024-03-18 06:24 pm | Society for Gynecologic Oncology Meeting |
| 2024-03-11 04:00 pm | Leerink Partners Global Biopharma Conference |
| 2024-03-09 10:13 am | European Society of Gynaecological Oncology Meeting |
| 2024-02-28 08:00 am | Q4 2023 Earnings Call |
| 2024-02-27 04:05 pm | Q4 2023 Earnings Release |
| 2024-01-08 06:45 pm | JPMorgan Healthcare Conference |
| 2023-11-29 12:55 pm | Evercore ISI HealthCONx Conference |
| 2023-11-15 08:00 am | Jefferies London Healthcare Conference |
Annual results
| Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 144 147 -2.08% | 215 216 -0.63% | 267 269 -0.77% | 396 | 591 | 928 |
|
EBITDA Million USD | Released Forecast Spread | -694 -614 -12.89% | -396 -425 6.86% | -358 -342 -4.68% | -311 | -213 | -41,3 |
|
EBIT Million USD | Released Forecast Spread | -700 -599 -16.82% | -404 -425 4.87% | -367 -351 -4.32% | -314 | -206 | 29,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -703 -613 -14.83% | -443 -463 4.37% | -335 -354 5.6% | -287 | -173 | 83,1 |
|
Net income Million USD | Released Forecast Spread | -704 -589 -19.52% | -443 -460 3.55% | -335 -348 3.74% | -289 | -168 | 68,5 |
|
EPS USD | Released Forecast Spread | -7,58 -6,87 -10.27% | -4,63 -4,93 6.02% | -3,46 -3,47 0.18% | -2,97 | -1,74 | 1,44 |
| Announcement Date | 01/03/22 | 01/03/23 | 27/02/24 | - |
Quarterly results
| Fiscal Period | June | 2022 Q3 | 2022 Q4 | 2022 S2 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 57,5 53,7 7.1% | 62,6 62,3 0.56% | 120 123 -2.04% | 62,8 65,5 -4.09% | 68,9 70,7 -2.56% | 69,2 66,7 3.84% | 65,8 72,1 -8.7% | 87,1 75,2 15.83% | 101 93,1 7.91% | 105 | 111 | 119 | 128 | 139 | 152 |
|
EBITDA Million USD | Released Forecast Spread | -122 -81,0 -50.07% | -67,3 -105 36.09% | -73,1 -67,9 -7.69% | -72,2 | -71,3 | ||||||||||
|
EBIT Million USD | Released Forecast Spread | -129 -112 -14.47% | -97,3 -108 10.22% | -226 -256 11.89% | -69,5 -93,3 25.51% | -89,5 -88,8 -0.84% | -83,6 -103 19.02% | -124 -89,0 -39.31% | -70,3 -96,8 27.38% | -76,1 -74,6 -1.96% | -81,3 | -82,5 | -61,2 | -61,2 | -59,2 | -54,8 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -161 -125 -29.02% | -61,8 -106 41.95% | -49,1 -90,2 45.54% | -121 -72,8 -66.06% | -69,2 -89,0 22.3% | -95,4 -81,0 -17.77% | -53,5 -93,1 42.55% | -80,3 -66,6 -20.54% | -73,0 | -71,9 | -53,6 | -54,0 | -52,4 | -48,3 | |
|
Net income Million USD | Released Forecast Spread | -161 -122 -31.74% | -61,8 -107 42.22% | -223 -183 -21.84% | -49,1 -90,0 45.41% | -121 -72,3 -67.14% | -69,2 -91,2 24.15% | -95,4 -84,8 -12.57% | -53,5 -91,7 41.69% | -80,3 -68,5 -17.2% | -75,3 | -75,5 | -53,6 | -54,0 | -52,4 | -48,3 |
|
EPS USD | Released Forecast Spread | -1,68 -1,27 -32.43% | -0,65 -1,12 41.72% | -0,51 -0,93 45.31% | -1,25 -0,75 -67.66% | -0,71 -0,94 24.44% | -0,98 -0,87 -12.69% | -0,55 -0,94 41.43% | -0,82 -0,70 -17.14% | -0,77 | -0,77 | -0,55 | -0,55 | -0,53 | -0,49 | |
| Announcement Date | 09/11/22 | 01/03/23 | 01/03/23 | 09/05/23 | 07/08/23 | 07/11/23 | 27/02/24 | 08/05/24 | 06/08/24 | - | - | - | - | - | - |
More events
Past sector events for Zai Lab Limited
| 2024-09-09 04:05 pm | AVID BIOSERVICES, INC.: Q1 2025 Earnings Release |
| 2024-09-05 06:30 am | KALVISTA PHARMACEUTICALS, INC.: Q1 2025 Earnings Release |
| 2024-08-30 11:56 pm | SHANGHAI JUNSHI BIOSCIENCES CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-30 | TONGHUA DONGBAO PHARMACEUTICAL CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | BEIJING BOHUI INNOVATION BIOTECHNOLOGY GROUP CO., LTD.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL VACCINE INC.: Q2 2024 Earnings Release |
| 2024-08-29 | HUALAN BIOLOGICAL ENGINEERING INC.: Q2 2024 Earnings Release |
| 2024-08-29 07:32 am | CLINUVEL PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
| 2024-08-28 | AIM VACCINE CO., LTD.: Q2 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZLAB Stock
- Calendar Zai Lab Limited